Hans Peter Bøhn
Chairman at PCI BIOTECH HOLDING ASA
Network origin in Hans Peter Bøhn first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 13 | |
SpinChip Diagnostics AS
 SpinChip Diagnostics AS Electronic Equipment/InstrumentsElectronic Technology SpinChip Diagnostics AS develops a game changing and proprietary platform for in vitro diagnostics point of care analyses. Its point of care device will satisfy all key user requirements, both with respect to assaying performance and user-friendliness. The firm's platform combines swift analysis and ease of use with wide range of advanced analyses. The company was founded by Stig Morten Borch in February 2012 and is headquartered in Oslo, Norway.
10
| Holding Company | Electronic Equipment/Instruments | 10 |
Zelluna Immunotherapy AS
 Zelluna Immunotherapy AS BiotechnologyHealth Technology Zelluna Immunotherapy AS engages in research and development on biotechnology. The company is headquartered in Oslo, Norway.
7
| Holding Company | Biotechnology | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Hans Peter Bøhn via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| BASF SE | Electrical Products | Corporate Officer/Principal | |
| AXIS-SHIELD LTD | Medical Specialties | Chief Executive Officer | |
| PHOTOCURE ASA | Medical Specialties | Chairman Director/Board Member | |
| AstraZeneca AS | Corporate Officer/Principal Corporate Officer/Principal | ||
GE Healthcare AS
 GE Healthcare AS Medical SpecialtiesHealth Technology GE Healthcare AS markets contrast agent for x-ray, ultrasound, Magnetic Resonance Imaging, and radiopharmaceuticals for clinicians to predict, diagnose, inform, and treat diseases. The company was founded on September 07, 1981 and it is headquartered in Oslo, Norway. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer | |
Union de Crédit Pour le Bâtiment SA
 Union de Crédit Pour le Bâtiment SA Finance/Rental/LeasingFinance Part of BNP Paribas SA, Union de Crédit Pour le Bâtiment SA is a mortgage services provider based in Paris, France. | Finance/Rental/Leasing | Chief Tech/Sci/R&D Officer | |
International Society for Cellular Therapy
 International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Birmingham | College/University | Doctorate Degree | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ARCTICZYMES TECHNOLOGIES ASA | Medical Specialties | Chief Executive Officer President Director/Board Member | |
| WEIFA ASA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Oslo | College/University | Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree | |
| Norwegian School of Economics & Business Administration | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
| BI Norwegian Business School | College/University | Graduate Degree Chairman Graduate Degree Graduate Degree | |
| University of Lisbon | College/University | Corporate Officer/Principal | |
| TXCELL | Miscellaneous Commercial Services | Chief Operating Officer | |
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The company is based in Amsterdam, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Aveiro | College/University | Corporate Officer/Principal | |
Omegatri AS
 Omegatri AS Food: Specialty/CandyConsumer Non-Durables Omegatri AS develops tablets and powders containing Omega-3 for the health and food industry. Its products include unique administration from for omega-3, no reflux, high oxidative stability, proven bioavailability, IP protected formulation, no gelation and no lactose. The company was founded by Jo Erik Johnsrud Klaveness and Pal Rongved in 2007 and is headquartered in Oslo, Norway. | Food: Specialty/Candy | Chairman Director/Board Member | |
siRNAsense AS
 siRNAsense AS Miscellaneous Commercial ServicesCommercial Services siRNAsense AS focuses on developing pipeline drugs. Its sources projects include Biotechnology Centre of Oslo, Centre for Molecular Biology and Neuroscience, Rikshospitalet-Radiumhospitalet HF and University of Oslo. The company was founded in December 2004 and is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Director/Board Member | |
Nextera AS
 Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| BERGENBIO ASA | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chairman | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
The Norwegian Academy of Science & Letters
 The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Nabi Pharmaceuticals | Chief Tech/Sci/R&D Officer | ||
| Chemlex AS | Director/Board Member | ||
| Biomedical Innovation AS | Director/Board Member | ||
| Biotechnology Centre of Oslo | Director/Board Member | ||
| HERANTIS PHARMA OYJ | Pharmaceuticals: Major | Director/Board Member | |
| COMBIGENE AB | Pharmaceuticals: Major | Director/Board Member | |
| Centre For Molecular Medicine Norway | Director/Board Member | ||
Blueprint Genetics Oy
 Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. | Biotechnology | Chairman | |
| SEDANA MEDICAL AB | Medical Specialties | Director/Board Member | |
PCI Biotech AS
 PCI Biotech AS BiotechnologyHealth Technology Part of PCI Biotech Holding ASA, PCI Biotech AS is a Norwegian company that engages in research and development in biotechnology. The company is based in Lysaker, Norway. | Biotechnology | Director/Board Member | |
| EXACT THERAPEUTICS | Biotechnology | Director/Board Member Chief Executive Officer Chairman Chief Tech/Sci/R&D Officer | |
Pluvia AS
 Pluvia AS Miscellaneous Commercial ServicesCommercial Services Pluvia AS operates as a research-based pharmaceutical company. The company is headquartered in Bergen, Norway. | Miscellaneous Commercial Services | Director/Board Member | |
Bio-Me AS
 Bio-Me AS BiotechnologyHealth Technology Bio-Me AS operates as a boi-tech firm. It researches and develops patented technologies and new approaches in bacteria analysis. The company is headquartered in Oslo, Norway. | Biotechnology | Director/Board Member | |
| Tappin AS | Director/Board Member | ||
| ONCOZENGE AB | Pharmaceuticals: Major | Director/Board Member | |
| Biotech Pharmacon ASA | Director/Board Member | ||
| Alertis AS | Director/Board Member | ||
| Afiew AS | Director/Board Member | ||
Accession Therapeutics Limited
 Accession Therapeutics Limited BiotechnologyHealth Technology Accession Therapeutics Limited is a British biotech company that is developing novel immuno-oncology therapeutics to eradicate cancers by harnessing the immune system more powerfully than ever before. The company is based in Oxford, UK and was founded in 2020 by Bent K. Jakobsen, who has been the CEO since then. The company's product, Trocept, is the first approach that meets the three requirements of being highly specific, broad in action to kill all cancer cell variants present, and potent in activating the full immune system arsenal local to the tumour. The team is built around successful biotech entrepreneurs experienced in taking projects through to the clinic and is supported by a Board comprising experienced international healthcare investors. | Biotechnology | Founder Director/Board Member |
Statistics
International
| Norway | 31 |
| Sweden | 6 |
| United Kingdom | 4 |
| France | 4 |
| Portugal | 3 |
Sectoral
| Health Technology | 25 |
| Commercial Services | 8 |
| Consumer Services | 7 |
| Producer Manufacturing | 2 |
| Finance | 2 |
Operational
| Director/Board Member | 115 |
| Corporate Officer/Principal | 57 |
| Chief Executive Officer | 26 |
| Independent Dir/Board Member | 25 |
| Chairman | 24 |
Most connected contacts
| Insiders | |
|---|---|
| Hilde Hermansen Steineger | 24 |
| Ann-Tove Kongsnes | 24 |
| Åse Aulie Michelet | 21 |
| Hilde Furberg | 21 |
| Svein Wilhelm Faye Lien | 18 |
| Morten Jurs | 15 |
| Christina Elisabeth Herder | 15 |
| Miguel Forte | 12 |
| Anders Tuv | 12 |
| Kjetil Taskén | 11 |
| Hans Ivar Robinson | 11 |
| Lars Kåre Viksmoen | 9 |
| Bent K. Jakobsen | 8 |
| Kristian Fredrik Huseby | 7 |
| Jan Fikkan | 6 |
- Stock Market
- Insiders
- Hans Peter Bøhn
- Company connections